Journals
Publish with us
Publishing partnerships
About us
Blog
Cardiovascular Therapeutics
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Cardiovascular Therapeutics
/
2024
/
Article
/
Tab 2
/
Research Article
Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure
Table 2
Anticoagulation complication comparison with NOACs for LAAC.
Rivaroxaban (
)
Dabigatran (
)
value
OR (95% CI)
Bleeding complications
Gastrointestinal hemorrhage (%)
4 (4.9%)
2 (5.3%)
0.928
0.927 (0.177-4.842)
Operation site hemorrhage (%)
2 (2.4%)
1 (2.6%)
0.950
0.927 (0.087-9.909)
Skin ecchymosis (%)
3 (3.7%)
2 (5.3%)
0.682
0.695 (0.121-3.990)
Laboratory parameters
(%)
7 (8.5%)
3 (7.9%)
0.906
1.081 (0.296-3.954)
Male:
(%)
4 (4.9%)
1 (2.6%)
0.567
1.854 (0.214-16.030)
Female:
(%)
OR: odds ratio; CI: confidence interval; PLT: platelet count; Hb: hemoglobin.